These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A. Hazlett LD; Berk RS; Iglewski BH Infect Immun; 1981 Dec; 34(3):1025-35. PubMed ID: 6800950 [TBL] [Abstract][Full Text] [Related]
27. Infectious agents in immunodeficient murine models: pathogenicity of Nocardia asteroides in congenitally athymic (nude) and hereditarily asplenic (Dh/+) mice. Beaman BL; Gershwin ME; Maslan S Infect Immun; 1978 May; 20(2):381-7. PubMed ID: 352942 [TBL] [Abstract][Full Text] [Related]
28. Aging alters the phagocytic capability of inflammatory cells induced into cornea. Hazlett LD; Kreindler FB; Berk RS; Barrett R Curr Eye Res; 1990 Feb; 9(2):129-38. PubMed ID: 2335110 [TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. Szliter EA; Lighvani S; Barrett RP; Hazlett LD J Immunol; 2007 Jan; 178(2):1105-14. PubMed ID: 17202374 [TBL] [Abstract][Full Text] [Related]
30. Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa. Preston MJ; Kernack K; Berk RS Infect Immun; 1993 Jun; 61(6):2713-6. PubMed ID: 8500912 [TBL] [Abstract][Full Text] [Related]
32. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480 [TBL] [Abstract][Full Text] [Related]
33. Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected with P. aeruginosa. Dong Z; Katar M; Alousi S; Berk RS Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3223-7. PubMed ID: 11726626 [TBL] [Abstract][Full Text] [Related]
34. Vascularization of corneas of hairless mutant mice. Niederkorn JY; Ubelaker JE; Martin JM Invest Ophthalmol Vis Sci; 1990 May; 31(5):948-53. PubMed ID: 1692313 [TBL] [Abstract][Full Text] [Related]
35. Studies on defense mechanisms against Candida albicans infection in congenitally athymic nude (nu/nu) mice. Tabeta H; Mikami Y; Abe F; Ommura Y; Arai T Mycopathologia; 1984 Feb; 84(2-3):107-13. PubMed ID: 6717553 [TBL] [Abstract][Full Text] [Related]
36. Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa. Cole N; Bao S; Willcox M; Husband AJ Infect Immun; 1999 May; 67(5):2497-502. PubMed ID: 10225913 [TBL] [Abstract][Full Text] [Related]
37. Analysis of adhesion, piliation, protease production and ocular infectivity of several P. aeruginosa strains. Hazlett LD; Moon MM; Singh A; Berk RS; Rudner XL Curr Eye Res; 1991 Apr; 10(4):351-62. PubMed ID: 1676963 [TBL] [Abstract][Full Text] [Related]
38. The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection. Khan S; Cole N; Hume EB; Garthwaite L; Conibear TC; Miles DH; Aliwaga Y; Krockenberger MB; Willcox MD J Leukoc Biol; 2007 Jan; 81(1):315-8. PubMed ID: 17028201 [TBL] [Abstract][Full Text] [Related]
39. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation. Kernacki KA; Barrett R; Hazlett LD Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939 [TBL] [Abstract][Full Text] [Related]
40. Intercellular adhesion molecule-2 (ICAM-2) and Pseudomonas aeruginosa ocular infection. Hobden JA DNA Cell Biol; 2003 Oct; 22(10):649-55. PubMed ID: 14611686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]